menu search

IMV / IMV Inc. to Present at Two Upcoming Investor Conferences

IMV Inc. to Present at Two Upcoming Investor Conferences
DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)--IMV Inc. (NASDAQ: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX platform to treat solid and hematologic cancers, today announced that members of IMV's executive management team will be participating in the 21st Annual Needham Virtual Annual Healthcare Conference, which will be held April 11-14, and the Wells Fargo Biotech Forum, which will be held April 12-13. 21st Read More
Posted: Apr 4 2022, 07:05
Author Name: Business Wire
Views: 112572

IMV News  

IMV Inc. to Announce Fourth Quarter and Fiscal Year 2022 Results and Host a Conference Call and Webcast on March 16, 2023

By Business Wire
March 9, 2023

IMV Inc. to Announce Fourth Quarter and Fiscal Year 2022 Results and Host a Conference Call and Webcast on March 16, 2023

DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $IMV #CancerVaccine--IMV Inc. (NASDAQ: IMV; TSX: IMV), a clinical-stage company develop more_horizontal

IMV, Inc. (IMV) Q3 2022 Earnings Call Transcript

By Seeking Alpha
November 12, 2022

IMV, Inc. (IMV) Q3 2022 Earnings Call Transcript

IMV, Inc. (NASDAQ:IMV ) Q3 2022 Earnings Conference Call November 11, 2022 8:00 AM ET Company Participants Brittany Davison - Chief Accounting Officer more_horizontal

IMV Inc. to Present at Two Investor Conferences in September

By Business Wire
September 1, 2022

IMV Inc. to Present at Two Investor Conferences in September

DARTMOUTH, Nova Scotia, & CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $IMV #DeliveryPlatform--IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage company dev more_horizontal

IMV Inc. to Announce Second Quarter 2022 Results and Host a Conference Call and Webcast on August 11, 2022

By Business Wire
August 4, 2022

IMV Inc. to Announce Second Quarter 2022 Results and Host a Conference Call and Webcast on August 11, 2022

DARTMOUTH, Nova Scotia, & CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $IMV #DeliveryPlatform--IMV Inc. (Nasdaq: IMV; TSX: IMV) (“IMV” or “the Company� more_horizontal

IMV to Present at IMMUNOLOGY™ 2022, the AAI Annual Meeting

By Business Wire
April 6, 2022

IMV to Present at IMMUNOLOGY™ 2022, the AAI Annual Meeting

DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)--IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immun more_horizontal

IMV Inc. to Present at Two Upcoming Investor Conferences

By Business Wire
April 4, 2022

IMV Inc. to Present at Two Upcoming Investor Conferences

DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)--IMV Inc. (NASDAQ: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immun more_horizontal

IMV Inc. (IMV) CEO Andrew Hall on Q4 2021 Results - Earnings Call Transcript

By Seeking Alpha
March 17, 2022

IMV Inc. (IMV) CEO Andrew Hall on Q4 2021 Results - Earnings Call Transcript

IMV Inc. (IMV) CEO Andrew Hall on Q4 2021 Results - Earnings Call Transcript more_horizontal


Search within

Pages Search Results: